Miranda L. Cheney

Polymorphs, Salts, and Cocrystals: What’s in a Name?

Gargi Mukherjee, Srinivasulu Aitipamula, Rahul Banerjee, 2012 .

Effects of Crystal Form on Solubility and Pharmacokinetics: A Crystal Engineering Case Study of Lamotrigine

Miranda L. Cheney, Michael J. Zaworotko, Ning Shan, 2010 .

Improving solubility and pharmacokinetics of meloxicam via multiple-component crystal formation.

Miranda L. Cheney, David R. Weyna, M. Zaworotko, 2012, Molecular pharmaceutics.

Excited state properties of 9-amino acridine surface adsorbed onto αZr-phosphate particles.

Miranda L. Cheney, M. Zaworotko, J. Perman, 2011, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

The Role of Cocrystals in Solid-State Synthesis: Cocrystal-Controlled Solid-State Synthesis of Imides

Miranda L. Cheney, M. Zaworotko, J. Perman, 2007 .

Supramolecular Architectures of Meloxicam Carboxylic Acid Cocrystals, a Crystal Engineering Case Study

Miranda L. Cheney, David R. Weyna, L. Wojtas, 2010 .

Crystal engineering of multiple-component organic solids: Pharmaceutical cocrystals of tadalafil with persistent hydrogen bonding motifs

Miranda L. Cheney, David R. Weyna, M. Zaworotko, 2012 .

Cocrystal Controlled Solid-State Synthesis: A Green Chemistry Experiment for Undergraduate Organic Chemistry.

Miranda L. Cheney, M. Zaworotko, R. Singer, 2008 .

Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics.

Miranda L. Cheney, David R. Weyna, Ning Shan, 2011, Journal of pharmaceutical sciences.

Correction for Polymorphs, Salts and Cocrystals: What’s in a Name?

Miranda L. Cheney, Amol G. Dikundwar, Preetam P. Ghogale, 2012 .